Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 6/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 6/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9339159 | 0.87 | MAPT (0.77) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL29260274 | 0.87 | MAPT (0.67) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL2446110 | 0.87 | MAPT (0.66) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL93271 | 0.87 | MAPT (1.00) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL30023422 | 0.87 | MAPT (0.66) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL27713896 | 0.86 | MAPT (0.76) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL28401771 | 0.85 | MAPT (0.64) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL25381912 | 0.85 | MAPT (0.64) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL7947089 | 0.84 | MAPT (0.62) | MAPTKDM4EHSD17B10MAPK1ALOX15 | |
| SCHEMBL7333834 | 0.84 | MAPT (0.63) | MAPTKDM4EHSD17B10MAPK1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114316846-A | Glue film composition containing polystyrene microspheres and preparation method and application thereof | 苏州赛伍应用技术股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114149769-A | High-reflection black adhesive film and preparation method and application thereof | 苏州赛伍应用技术股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| EP-0360353-A2 | Plate of material with polymeric structure, resistant to sun light | LA/ES LAMINATI ESTRUSI TERMOPLASTICI S.P.A. (IT) | 1990-03-28 | — | — | EP | claimed |
| CN-114316846-A | Glue film composition containing polystyrene microspheres and preparation method and application thereof | 苏州赛伍应用技术股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114149769-A | High-reflection black adhesive film and preparation method and application thereof | 苏州赛伍应用技术股份有限公司 | 2022-03-08 | — | — | CN | disclosed |
| US-20150218336-A1 | UV ABSORBERS ON PIGMENTS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-08-06 | — | — | US | disclosed |
| WO-2014028007-A1 | UV ABSORBERS ON PIGMENTS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-02-20 | — | — | WO | disclosed |
| US-20080269191-A1 | Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases | PTC THERAPEUTICS, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| US-20080269191-A1 | Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases | PTC THERAPEUTICS, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| CN-1714121-A | Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation | BASF AG (DE) | 2005-12-28 | — | — | CN | disclosed |
| EP-1565522-A2 | USE OF POLYMER POWDER CONTAINING UV ABSORBER FOR THE STABILISATION OF POLYMERS AGAINST THE EFFECTS OF UV RADIATION | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-24 | — | — | EP | disclosed |
| EP-1392283-A4 | SUBSTITUTED COUMARINS AND QUINOLINES AS CASPASE ACTIVATORS | CYTOVIA INC (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2004046234-A2 | USE OF POLYMER POWDER CONTAINING UV ABSORBER FOR THE STABILISATION OF POLYMERS AGAINST THE EFFECTS OF UV RADIATION | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-03 | — | — | WO | disclosed |
| EP-1392283-A1 | SUBSTITUTED COUMARINS AND QUINOLINES AS CASPASES ACTIVATORS | Cytovia, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002092076-A1 | SUBSTITUTED COUMARINS AND QUINOLINES AS CASPASES ACTIVATORS | CYTOVIA, INC. (US) | 2002-11-21 | — | — | WO | disclosed |
| EP-0442068-B1 | Benzophenone derivatives and polymers containing phenolic hydroxyl groups | BAYER AG (DE) | 1994-06-08 | — | — | EP | disclosed |
| EP-0442068-A2 | Benzophenone derivatives and polymers containing phenolic hydroxyl groups | BAYER AG (DE) | 1991-08-21 | — | — | EP | disclosed |
| EP-0360353-A2 | Plate of material with polymeric structure, resistant to sun light | LA/ES LAMINATI ESTRUSI TERMOPLASTICI S.P.A. (IT) | 1990-03-28 | — | — | EP | disclosed |
| US-4022908-A | Use of certain 2-nitro-3-phenyl-alkoxybenzofurans in inhibiting growth of microorganisms and intermediates in the synthesis of said benzofurans | RIKER LABORATORIES, INC. (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269191-A1 | Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases | UPF1, NSUN2, RNMT | MAPT 2955/4885KDM4E 1079/4885HSD17B10 3455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.